GlassScriptPhysician profile
Alida M Espinoza
NPI 1033145321
$22,767.23
in general payments reported to CMS, 2019-2025
90 companies · $4,920 in 2025
The $4,920 reported for 2025 was more than what 82% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,596 · 2020: $1,953 · 2021: $3,365 · 2022: $3,803 · 2023: $3,147 · 2024: $3,983 · 2025: $4,920.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,648 · Long Term Medical Supply Or Device Loan: $2,046 · Education: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,648.14 |
| Long Term Medical Supply Or Device Loan | $2,046.07 |
| Education | $355.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $4,358.64 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,187.67 | 2019-2025 | Reblozyl, Opdivo, Pomalyst |
| Janssen Biotech, INC. | $1,055.91 | 2020-2025 | Tecvayli, Darzalex, Talvey |
| Merck Sharp & Dohme LLC | $885.75 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Astrazeneca Pharmaceuticals LP | $840.08 | 2019-2025 | Lynparza, Calquence, Enhertu |
| Genzyme Corporation | $615.54 | 2020-2025 | |
| Daiichi Sankyo INC. | $576.88 | 2019-2025 | Enhertu, Injectafer |
| Aveo Pharmaceuticals, INC. | $566.80 | 2022-2025 | Fotivda |
| Incyte Corporation | $559.43 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Abbvie INC. | $552.52 | 2019-2025 | |
| Eisai INC. | $546.79 | 2019-2025 | |
| Seagen INC. | $546.34 | 2020-2023 | Tukysa, Tivdak, Adcetris |
| Pfizer INC. | $543.34 | 2019-2025 | |
| Glaxosmithkline, LLC. | $542.58 | 2020-2025 | Zejula, Jemperli, Ojjaara |
| Genentech USA, INC. | $481.46 | 2019-2025 | Lunsumio, Polivy, Tecentriq |
Show all 90 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $432.36 | 2019-2025 | Iclusig, Alunbrig, Ninlaro |
| Regeneron Healthcare Solutions, INC. | $411.93 | 2019-2025 | Libtayo |
| Celgene Corporation | $370.54 | 2019-2025 | Reblozyl, Pomalyst |
| Amgen INC. | $346.53 | 2019-2023 | Lumakras, Nplate, Xgeva |
| Pharmacyclics LLC, An Abbvie Company | $345.42 | 2019-2023 | Imbruvica |
| Bayer Healthcare Pharmaceuticals INC. | $316.09 | 2020-2025 | |
| Puma Biotechnology, INC. | $303.57 | 2019-2025 | |
| Ipsen Biopharmaceuticals, INC | $299.76 | 2019-2025 | Onivyde, Tazverik |
| Lilly USA, LLC | $280.62 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Pharmaessentia USA Corporation | $272.90 | 2022-2025 | Besremi |
| Sobi, INC | $260.31 | 2022-2025 | |
| Exelixis INC. | $231.86 | 2019-2025 | Cabometyx |
| Rigel Pharmaceuticals, INC. | $230.80 | 2020-2025 | Rezlidhia, Tavalisse, Gavreto |
| Adc Therapeutics America, INC. | $230.33 | 2022-2025 | |
| Global Blood Therapeutics, INC. | $220.93 | 2020-2022 | |
| Dendreon Pharmaceuticals LLC | $205.04 | 2020-2025 | Provenge |
| Boehringer Ingelheim Pharmaceuticals, INC. | $195.99 | 2019-2025 | |
| Taiho Oncology, INC. | $184.49 | 2022-2025 | |
| Tersera Therapeutics LLC | $180.23 | 2019-2025 | Xermelo, Quzyttir, Zoladex |
| Beigene USA, INC. | $173.82 | 2022-2024 | Brukinsa |
| Genmab U.S., INC. | $170.08 | 2023-2025 | Epkinly |
| Astellas Pharma US INC | $139.99 | 2021-2025 | Padcev, Vyloy |
| Tempus Ai, INC | $132.47 | 2024-2025 | Xt Cdx |
| Karyopharm Therapeutics INC. | $131.34 | 2020-2024 | Xpovio |
| Pharmacosmos Therapeutics INC. | $125.32 | 2022-2025 | Monoferric |
| Adaptive Biotechnologies Corporation | $117.14 | 2022-2025 | Clonoseq |
| Emd Serono, INC. | $111.49 | 2020-2025 | |
| Gilead Sciences, INC. | $106.32 | 2021-2025 | Trodelvy |
| Servier Pharmaceuticals LLC | $105.98 | 2021-2025 | |
| Array Biopharma INC | $102.38 | 2019-2025 | Mektovi, Braftovi, Lorbrena |
| Mirati Therapeutics, INC. | $100.66 | 2023-2024 | Krazati |
| Janssen Pharmaceuticals, INC | $100.43 | 2022-2025 | Erleada, Xarelto |
| Beone Medicines USA, INC. | $96.58 | 2025 | Brukinsa |
| Stemline Therapeutics INC. | $93.95 | 2023-2025 | Orserdu |
| Agios Pharmaceuticals, INC. | $93.66 | 2024-2025 | Pyrukynd |
| Blueprint Medicines Corporation | $92.05 | 2021-2025 | Ayvakit |
| Tactile Systems Technology INC | $86.48 | 2021-2025 | Nimbl, Flexitouch Plus |
| Kyowa Kirin, INC. | $84.73 | 2022-2024 | Poteligeo |
| Heron Therapeutics, INC. | $84.58 | 2019-2023 | Sustol |
| G1 Therapeutics, INC. | $78.82 | 2021-2023 | Cosela |
| Janssen Scientific Affairs, LLC | $77.81 | 2019 | |
| Kite Pharma, INC. | $75.04 | 2019-2024 | Yescarta |
| Sumitomo Pharma America, INC. | $75.01 | 2023-2025 | Orgovyx |
| Morphosys, US INC. | $64.02 | 2021-2023 | Monjuvi |
| Deciphera Pharmaceuticals INC. | $62.02 | 2021-2025 | Qinlock, Tgct |
| Syndax Pharmaceuticals, INC. | $55.70 | 2025 | |
| Alexion Pharmaceuticals, INC. | $53.48 | 2020-2022 | |
| Shire North American Group INC | $48.90 | 2019 | |
| Tesaro, INC. | $48.74 | 2019 | |
| Shield Therapeutics INC | $48.63 | 2024 | |
| Springworks Therapeutics, INC. | $44.02 | 2024-2025 | Ogsiveo |
| Eusa Pharma (US) LLC | $43.28 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $39.19 | 2020-2023 | Givlaari |
| Epizyme, INC. | $35.30 | 2020-2022 | |
| Amag Pharmaceuticals, INC. | $33.99 | 2019-2020 | |
| Clovis Oncology, INC. | $32.86 | 2020 | |
| Foundation Medicine, INC. | $32.47 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $29.59 | 2021-2022 | |
| Iovance Biotherapeutics, INC. | $27.17 | 2025 | Amtagvi |
| Jazz Pharmaceuticals INC. | $26.94 | 2019 | |
| Immunogen, INC. | $25.15 | 2023 | Elahere |
| Tg Therapeutics, INC. | $24.90 | 2021 | |
| Fresenius Kabi USA, LLC | $24.43 | 2025 | Stimufend |
| Fennec Pharmaceuticals, INC. | $24.41 | 2025 | Fyarro |
| Telix Pharmaceuticals | $23.35 | 2023 | Illuccix |
| Sandoz INC. | $22.34 | 2025 | Cyclophosphamide, Ziextenzo |
| Coherus Oncology, INC. | $19.58 | 2021 | |
| Legend Biotech USA INC. | $19.56 | 2025 | Carvykti |
| Verastem, INC. | $19.06 | 2019 | |
| Boston Scientific Corporation | $19.03 | 2024 | |
| Novocure INC. | $17.22 | 2020 | |
| Acrotech Biopharma INC. | $17.07 | 2023 | Beleodaq |
| Spectrum Pharmaceuticals INC. | $16.84 | 2025 | Rolvedon |
| Aurobindo Pharma USA, INC. | $16.59 | 2020 | |
| Azurity Pharmaceuticals, INC. | $15.84 | 2025 | Danziten |
Drugs and devices associated with these payments
Kisqali $2,094Keytruda $500Enhertu $473Fotivda $416Reblozyl $347Libtayo $306Tecvayli $265Epkinly $239Lenvima $236Zejula $235Lynparza $231Darzalex $230Besremi $206Brukinsa $206Jemperli $203Venclexta $182Cabometyx $172Talvey $172Scemblix $167Erleada $157Carvykti $157Pomalyst $154Opdivo $152Provenge $145Verzenio $140Jaypirca $140Jakafi $134Rezlidhia $130Tavalisse $130Monjuvi $125Stivarga $122Imbruvica $121Lonsurf $116Inqovi $116Tukysa $111Iclusig $110Onivyde $109Padcev $106Doptelet $103Xt Cdx $103Vonjo $101Krazati $101Nubeqa $99.78Orgovyx $99.52Retevmo $96.89Welireg $94.99Orserdu $93.95Pyrukynd $93.66Zynlonta $93.03Adcetris $92.97Calquence $86.62Monoferric $78.40Clonoseq $78.36Keytruda Qlex $74.16Rybrevant $72.87Vitrakvi $72.44Lutathera $71.21Injectafer $69.53Polivy $65.79Lunsumio $65.79Tecentriq $64.35Fabhalta $63.82Gavreto $63.71Poteligeo $62.05Elrexfio $61.58Imfinzi $59.68Elahere $59.10Xpovio $58.28Xofigo $57.69Tazverik $57.51Zynyz $57.43Sarclisa $54.94Trodelvy $53.50Nerlynx $51.35Jevtana $50.21Tivdak $48.69Accrufer $48.63Ibrance $48.12Oxbryta $47.40Illuccix $46.70Columvi $46.40Yescarta $45.35Ojjaara $45.32Braftovi $44.38Lorbrena $44.38Mektovi $44.38Ogsiveo $44.02Cosela $43.66Pemazyre $43.42Voranigo $39.07Xermelo $36.71Piqray $32.38Sustol $31.92Pluvicto $31.31Ayvakit $31.20Qinlock $28.83Lumakras $27.92Givlaari $27.42Amtagvi $27.17Alunbrig $27.01
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alida Espinoza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.